Circulating EVs for AML minimal residual disease biomarkers detection: PS229

P C Nunes1, H R Caires2, M A Sobrinho-Simões3

  • 1Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Portugal; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, Portugal; ICBAS-UP - Institute of Biomedical Sciences Abel Salazar of the University of Porto, Portugal.

Abstract

No abstract available in PubMed .

Related Concept Videos